What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review

go back to reference Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ (2022) IDF Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119PubMedCrossRef Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ (2022) IDF Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119PubMedCrossRef

go back to reference Gong W, Jiao Q, Yuan J, Luo H, Liu Y, Zhang Y, Chen Z, Xu X, Bai L, Zhang X (2023) Cardioprotective and anti-inflammatory effects of caveolin 1 in experimental diabetic cardiomyopathy. Clin Sci (Lond) 137(6):511–525PubMedCrossRef Gong W, Jiao Q, Yuan J, Luo H, Liu Y, Zhang Y, Chen Z, Xu X, Bai L, Zhang X (2023) Cardioprotective and anti-inflammatory effects of caveolin 1 in experimental diabetic cardiomyopathy. Clin Sci (Lond) 137(6):511–525PubMedCrossRef

go back to reference Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57(4):660–671PubMedPubMedCentralCrossRef Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57(4):660–671PubMedPubMedCentralCrossRef

go back to reference Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3(3):219–228PubMedCrossRef Cai L, Kang YJ (2003) Cell death and diabetic cardiomyopathy. Cardiovasc Toxicol 3(3):219–228PubMedCrossRef

go back to reference Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595–602PubMedCrossRef Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595–602PubMedCrossRef

go back to reference Peterson LR, Gropler RJ (2020) Metabolic and molecular imaging of the diabetic cardiomyopathy. Circ Res 126(11):1628–1645PubMedPubMedCentralCrossRef Peterson LR, Gropler RJ (2020) Metabolic and molecular imaging of the diabetic cardiomyopathy. Circ Res 126(11):1628–1645PubMedPubMedCentralCrossRef

go back to reference Kabbage M, Kessens R, Bartholomay LC, Williams B (2017) The life and death of a plant cell. Annu Rev Plant Biol 68:375–404PubMedCrossRef Kabbage M, Kessens R, Bartholomay LC, Williams B (2017) The life and death of a plant cell. Annu Rev Plant Biol 68:375–404PubMedCrossRef

go back to reference Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev 99(4):1765–1817PubMedPubMedCentralCrossRef Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev 99(4):1765–1817PubMedPubMedCentralCrossRef

go back to reference Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072PubMedPubMedCentralCrossRef Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060–1072PubMedPubMedCentralCrossRef

go back to reference Doll S, Conrad M (2017) Iron and ferroptosis: a still ill-defined liaison. IUBMB Life 69(6):423–434PubMedCrossRef Doll S, Conrad M (2017) Iron and ferroptosis: a still ill-defined liaison. IUBMB Life 69(6):423–434PubMedCrossRef

go back to reference Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bayir H (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13(1):81–90PubMedCrossRef Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, Kapralov AA, Amoscato AA, Jiang J, Anthonymuthu T, Mohammadyani D, Yang Q, Proneth B, Klein-Seetharaman J, Watkins S, Bahar I, Greenberger J, Mallampalli RK, Stockwell BR, Tyurina YY, Conrad M, Bayir H (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13(1):81–90PubMedCrossRef

go back to reference Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34PubMedPubMedCentralCrossRef Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1):34PubMedPubMedCentralCrossRef

go back to reference Fang X, Ardehali H, Min J, Wang F (2023) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol 20(1):7–23PubMedCrossRef Fang X, Ardehali H, Min J, Wang F (2023) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol 20(1):7–23PubMedCrossRef

go back to reference De Geest B, Mishra M (2022) Role of oxidative stress in diabetic cardiomyopathy. Antioxidants (Basel) 11(4) De Geest B, Mishra M (2022) Role of oxidative stress in diabetic cardiomyopathy. Antioxidants (Basel) 11(4)

go back to reference Authors/Task Force Members, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34(39):3035–3087CrossRef Authors/Task Force Members, Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Document R, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J 34(39):3035–3087CrossRef

go back to reference Boyer JK, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93(7):870–875PubMedCrossRef Boyer JK, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93(7):870–875PubMedCrossRef

go back to reference Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122(4):624–638PubMedPubMedCentralCrossRef Jia G, Hill MA, Sowers JR (2018) Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 122(4):624–638PubMedPubMedCentralCrossRef

go back to reference Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101(19):2271–2276PubMedCrossRef Devereux RB, Roman MJ, Paranicas M, O’Grady MJ, Lee ET, Welty TK, Fabsitz RR, Robbins D, Rhoades ER, Howard BV (2000) Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101(19):2271–2276PubMedCrossRef

go back to reference Park JW, Ziegler AG, Janka HU, Doering W, Mehnert H (1988) Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study. Klin Wochenschr 66(17):773–778PubMedCrossRef Park JW, Ziegler AG, Janka HU, Doering W, Mehnert H (1988) Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study. Klin Wochenschr 66(17):773–778PubMedCrossRef

go back to reference Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I (1993) Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46(1):32–36PubMedPubMedCentralCrossRef Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I (1993) Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46(1):32–36PubMedPubMedCentralCrossRef

go back to reference Dawson A, Morris AD, Struthers AD (2005) The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 48(10):1971–1979PubMedCrossRef Dawson A, Morris AD, Struthers AD (2005) The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus. Diabetologia 48(10):1971–1979PubMedCrossRef

go back to reference Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22):1561–1566PubMedCrossRef Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22):1561–1566PubMedCrossRef

go back to reference Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, Wang Y, Wang JA, Xiang M (2017) EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-beta/Smad3 signaling. Circ Res 121(6):617–627PubMedCrossRef Su SA, Yang D, Wu Y, Xie Y, Zhu W, Cai Z, Shen J, Fu Z, Wang Y, Jia L, Wang Y, Wang JA, Xiang M (2017) EphrinB2 regulates cardiac fibrosis through modulating the interaction of Stat3 and TGF-beta/Smad3 signaling. Circ Res 121(6):617–627PubMedCrossRef

go back to reference Li CJ, Lv L, Li H, Yu DM (2012) Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol 11:73PubMedPubMedCentralCrossRef Li CJ, Lv L, Li H, Yu DM (2012) Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid. Cardiovasc Diabetol 11:73PubMedPubMedCentralCrossRef

go back to reference Murtaza G, Virk HUH, Khalid M, Lavie CJ, Ventura H, Mukherjee D, Ramu V, Bhogal S, Kumar G, Shanmugasundaram M, Paul TK (2019) Diabetic cardiomyopathy - a comprehensive updated review. Prog Cardiovasc Dis 62(4):315–326PubMedCrossRef Murtaza G, Virk HUH, Khalid M, Lavie CJ, Ventura H, Mukherjee D, Ramu V, Bhogal S, Kumar G, Shanmugasundaram M, Paul TK (2019) Diabetic cardiomyopathy - a comprehensive updated review. Prog Cardiovasc Dis 62(4):315–326PubMedCrossRef

go back to reference Aragno M, Mastrocola R, Alloatti G, Vercellinatto I, Bardini P, Geuna S, Catalano MG, Danni O, Boccuzzi G (2008) Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149(1):380–388PubMedCrossRef Aragno M, Mastrocola R, Alloatti G, Vercellinatto I, Bardini P, Geuna S, Catalano MG, Danni O, Boccuzzi G (2008) Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149(1):380–388PubMedCrossRef

go back to reference Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Bohm M, Pauschinger M, Schultheiss HP, Tschope C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103(4):319–327PubMedCrossRef Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Bohm M, Pauschinger M, Schultheiss HP, Tschope C (2008) Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 103(4):319–327PubMedCrossRef

go back to reference Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 17(9):585–607PubMedPubMedCentralCrossRef Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L (2020) Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol 17(9):585–607PubMedPubMedCentralCrossRef

go back to reference Byrne NJ, Rajasekaran NS, Abel ED, Bugger H (2021) Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med 169:317–342PubMedPubMedCentralCrossRef Byrne NJ, Rajasekaran NS, Abel ED, Bugger H (2021) Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy. Free Radic Biol Med 169:317–342PubMedPubMedCentralCrossRef

go back to reference Jayakumar D (2022) KK SN, Periandavan K: Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: from health to disease. J Trace Elem Med Biol 69:126882PubMedCrossRef Jayakumar D (2022) KK SN, Periandavan K: Triad role of hepcidin, ferroportin, and Nrf2 in cardiac iron metabolism: from health to disease. J Trace Elem Med Biol 69:126882PubMedCrossRef

go back to reference Li JY, Liu SQ, Yao RQ, Tian YP, Yao YM (2021) A novel insight into the fate of cardiomyocytes in ischemia-reperfusion injury: from iron metabolism to ferroptosis. Front Cell Dev Biol 9:799499PubMedPubMedCentralCrossRef Li JY, Liu SQ, Yao RQ, Tian YP, Yao YM (2021) A novel insight into the fate of cardiomyocytes in ischemia-reperfusion injury: from iron metabolism to ferroptosis. Front Cell Dev Biol 9:799499PubMedPubMedCentralCrossRef

go back to reference Wang S, Ding L, Ji H, Xu Z, Liu Q, Zheng Y (2016) The role of p38 MAPK in the development of diabetic cardiomyopathy. Int J Mol Sci 17(7) Wang S, Ding L, Ji H, Xu Z, Liu Q, Zheng Y (2016) The role of p38 MAPK in the development of diabetic cardiomyopathy. Int J Mol Sci 17(7)

go back to reference Faria A, Persaud SJ (2017) Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther 172:50–62PubMedCrossRef Faria A, Persaud SJ (2017) Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential. Pharmacol Ther 172:50–62PubMedCrossRef

go back to reference Eid RA, Alkhateeb MA, El-Kott AF, Eleawa SM, Zaki MSA, Alaboodi SA, Salem Al-Shudiefat AA, Aldera H, Alnamar NM, Alassiri M, Khalil MA (2019) A high-fat diet rich in corn oil induces cardiac fibrosis in rats by activating JAK2/STAT3 and subsequent activation of ANG II/TGF-1beta/Smad3 pathway: the role of ROS and IL-6 trans-signaling. J Food Biochem 43(8):e12952PubMedCrossRef Eid RA, Alkhateeb MA, El-Kott AF, Eleawa SM, Zaki MSA, Alaboodi SA, Salem Al-Shudiefat AA, Aldera H, Alnamar NM, Alassiri M, Khalil MA (2019) A high-fat diet rich in corn oil induces cardiac fibrosis in rats by activating JAK2/STAT3 and subsequent activation of ANG II/TGF-1beta/Smad3 pathway: the role of ROS and IL-6 trans-signaling. J Food Biochem 43(8):e12952PubMedCrossRef

go back to reference Ou M, Jiang Y, Ji Y, Zhou Q, Du Z, Zhu H, Zhou Z (2022) Role and mechanism of ferroptosis in neurological diseases. Mol Metab 61:101502PubMedPubMedCentralCrossRef Ou M, Jiang Y, Ji Y, Zhou Q, Du Z, Zhu H, Zhou Z (2022) Role and mechanism of ferroptosis in neurological diseases. Mol Metab 61:101502PubMedPubMedCentralCrossRef

go back to reference Wang F, Lv H, Zhao B, Zhou L, Wang S, Luo J, Liu J, Shang P (2019) Iron and leukemia: new insights for future treatments. J Exp Clin Cancer Res 38(1):406PubMedPubMedCentralCrossRef Wang F, Lv H, Zhao B, Zhou L, Wang S, Luo J, Liu J, Shang P (2019) Iron and leukemia: new insights for future treatments. J Exp Clin Cancer Res 38(1):406PubMedPubMedCentralCrossRef

go back to reference Silva I, Rausch V, Peccerella T, Millonig G, Seitz HK, Mueller S (2018) Hypoxia enhances H(2)O(2)-mediated upregulation of hepcidin: evidence for NOX4-mediated iron regulation. Redox Biol 16:1–10PubMedPubMedCentralCrossRef Silva I, Rausch V, Peccerella T, Millonig G, Seitz HK, Mueller S (2018) Hypoxia enhances H(2)O(2)-mediated upregulation of hepcidin: evidence for NOX4-mediated iron regulation. Redox Biol 16:1–10PubMedPubMedCentralCrossRef

go back to reference Stehling O, Sheftel AD, Lill R (2009) Chapter 12 controlled expression of iron-sulfur cluster assembly components for respiratory chain complexes in mammalian cells. Methods Enzymol 456:209–231PubMedCrossRef Stehling O, Sheftel AD, Lill R (2009) Chapter 12 controlled expression of iron-sulfur cluster assembly components for respiratory chain complexes in mammalian cells. Methods Enzymol 456:209–231PubMedCrossRef

go back to reference Anderson GJ, Frazer DM (2017) Current understanding of iron homeostasis. Am J Clin Nutr 106(Suppl 6):1559S-1566SPubMedPubMedCentralCrossRef Anderson GJ, Frazer DM (2017) Current understanding of iron homeostasis. Am J Clin Nutr 106(Suppl 6):1559S-1566SPubMedPubMedCentralCrossRef

go back to reference Fuqua BK, Vulpe CD, Anderson GJ (2012) Intestinal iron absorption. J Trace Elem Med Biol 26(2–3):115–119PubMedCrossRef Fuqua BK, Vulpe CD, Anderson GJ (2012) Intestinal iron absorption. J Trace Elem Med Biol 26(2–3):115–119PubMedCrossRef

go back to reference Drakesmith H, Nemeth E, Ganz T (2015) Ironing out ferroportin. Cell Metab 22(5):777–787PubMedPubMedCentralCrossRef Drakesmith H, Nemeth E, Ganz T (2015) Ironing out ferroportin. Cell Metab 22(5):777–787PubMedPubMedCentralCrossRef

go back to reference Li D, Pi W, Sun Z, Liu X, Jiang J (2022) Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother 153:113279PubMedCrossRef Li D, Pi W, Sun Z, Liu X, Jiang J (2022) Ferroptosis and its role in cardiomyopathy. Biomed Pharmacother 153:113279PubMedCrossRef

go back to reference Krijt M, Jirkovska A, Kabickova T, Melenovsky V, Petrak J, Vyoral D (2018) Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using (55)Fe and storage phosphorimaging. Biochim Biophys Acta Gen Subj 1862(12):2895–2901PubMedCrossRef Krijt M, Jirkovska A, Kabickova T, Melenovsky V, Petrak J, Vyoral D (2018) Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using (55)Fe and storage phosphorimaging. Biochim Biophys Acta Gen Subj 1862(12):2895–2901PubMedCrossRef

go back to reference Stoyanovsky DA, Tyurina YY, Shrivastava I, Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV, Vladimirov YA, Shvedova AA, Philpott CC, Bayir H, Kagan VE (2019) Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med 133:153–161PubMedCrossRef Stoyanovsky DA, Tyurina YY, Shrivastava I, Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV, Vladimirov YA, Shvedova AA, Philpott CC, Bayir H, Kagan VE (2019) Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med 133:153–161PubMedCrossRef

go back to reference Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15(3):234–245PubMedPubMedCentralCrossRef Yang WS, Stockwell BR (2008) Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol 15(3):234–245PubMedPubMedCentralCrossRef

go back to reference Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X (2016) Ferroptosis is an autophagic cell death process. Cell Res 26(9):1021–1032PubMedPubMedCentralCrossRef Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X (2016) Ferroptosis is an autophagic cell death process. Cell Res 26(9):1021–1032PubMedPubMedCentralCrossRef

go back to reference Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D (2020) Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol 27(4):420–435PubMedPubMedCentralCrossRef Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D (2020) Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol 27(4):420–435PubMedPubMedCentralCrossRef

go back to reference Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509(7498):105–109ADSPubMedPubMedCentralCrossRef Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509(7498):105–109ADSPubMedPubMedCentralCrossRef

go back to reference Kuno S, Fujita H, Tanaka YK, Ogra Y, Iwai K (2022) Iron-induced NCOA4 condensation regulates ferritin fate and iron homeostasis. EMBO Rep 23(5):e54278PubMedPubMedCentralCrossRef Kuno S, Fujita H, Tanaka YK, Ogra Y, Iwai K (2022) Iron-induced NCOA4 condensation regulates ferritin fate and iron homeostasis. EMBO Rep 23(5):e54278PubMedPubMedCentralCrossRef

go back to reference Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G, Cantwell J, Luu C, Cornella-Taracido I, Harrington E, Fekkes P, Lei H, Fang Q, Digan ME, Burdick D, Powers AF, Helliwell SB, D’Aquin S, Bastien J, Wang H, Wiederschain D, Kuerth J, Bergman P, Schwalb D, Thomas J, Ugwonali S, Harbinski F, Tallarico J, Wilson CJ, Myer VE, Porter JA, Bussiere DE, Finan PM, Labow MA, Mao X, Hamann LG, Manning BD, Valdez RA, Nicholson T, Schirle M, Knapp MS, Keaney EP, Murphy LO (2014) Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol 16(11):1069–1079PubMedCrossRef Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G, Cantwell J, Luu C, Cornella-Taracido I, Harrington E, Fekkes P, Lei H, Fang Q, Digan ME, Burdick D, Powers AF, Helliwell SB, D’Aquin S, Bastien J, Wang H, Wiederschain D, Kuerth J, Bergman P, Schwalb D, Thomas J, Ugwonali S, Harbinski F, Tallarico J, Wilson CJ, Myer VE, Porter JA, Bussiere DE, Finan PM, Labow MA, Mao X, Hamann LG, Manning BD, Valdez RA, Nicholson T, Schirle M, Knapp MS, Keaney EP, Murphy LO (2014) Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nat Cell Biol 16(11):1069–1079PubMedCrossRef

go back to reference Gao M, Monian P, Quadri N, Ramasamy R, Jiang X (2015) Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 59(2):298–308PubMedPubMedCentralCrossRef Gao M, Monian P, Quadri N, Ramasamy R, Jiang X (2015) Glutaminolysis and transferrin regulate ferroptosis. Mol Cell 59(2):298–308PubMedPubMedCentralCrossRef

go back to reference Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng ZY (2019) Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019:5080843PubMedPubMedCentralCrossRef Su LJ, Zhang JH, Gomez H, Murugan R, Hong X, Xu D, Jiang F, Peng ZY (2019) Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019:5080843PubMedPubMedCentralCrossRef

go back to reference Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113(34):E4966-4975ADSPubMedPubMedCentralCrossRef Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A 113(34):E4966-4975ADSPubMedPubMedCentralCrossRef

go back to reference Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273–285PubMedPubMedCentralCrossRef Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273–285PubMedPubMedCentralCrossRef

go back to reference Ursini F, Maiorino M (2020) Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 152:175–185PubMedCrossRef Ursini F, Maiorino M (2020) Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 152:175–185PubMedCrossRef

go back to reference Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266–282PubMedPubMedCentralCrossRef Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266–282PubMedPubMedCentralCrossRef

go back to reference Stockwell BR (2022) Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401–2421PubMedPubMedCentralCrossRef Stockwell BR (2022) Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185(14):2401–2421PubMedPubMedCentralCrossRef

go back to reference van den Brink-van der Laan E, Killian JA, de Kruijff B (2004) Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim Biophys Acta 1666(1–2):275–288PubMedCrossRef van den Brink-van der Laan E, Killian JA, de Kruijff B (2004) Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim Biophys Acta 1666(1–2):275–288PubMedCrossRef

go back to reference Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA (2017) On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci 3(3):232–243PubMedPubMedCentralCrossRef Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA (2017) On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci 3(3):232–243PubMedPubMedCentralCrossRef

go back to reference Laddha AP, Kulkarni YA (2020) NADPH oxidase: a membrane-bound enzyme and its inhibitors in diabetic complications. Eur J Pharmacol 881:173206PubMedCrossRef Laddha AP, Kulkarni YA (2020) NADPH oxidase: a membrane-bound enzyme and its inhibitors in diabetic complications. Eur J Pharmacol 881:173206PubMedCrossRef

go back to reference Dhalla NS, Shah AK, Tappia PS (2020) Role of oxidative stress in metabolic and subcellular abnormalities in diabetic cardiomyopathy. Int J Mol Sci 21(7) Dhalla NS, Shah AK, Tappia PS (2020) Role of oxidative stress in metabolic and subcellular abnormalities in diabetic cardiomyopathy. Int J Mol Sci 21(7)

go back to reference Shu T, Lv Z, Xie Y, Tang J, Mao X (2019) Hepcidin as a key iron regulator mediates glucotoxicity-induced pancreatic beta-cell dysfunction. Endocr Connect 8(3):150–161PubMedPubMedCentralCrossRef Shu T, Lv Z, Xie Y, Tang J, Mao X (2019) Hepcidin as a key iron regulator mediates glucotoxicity-induced pancreatic beta-cell dysfunction. Endocr Connect 8(3):150–161PubMedPubMedCentralCrossRef

go back to reference Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L (2009) Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem 16(1):113–129PubMedCrossRef Liu Q, Sun L, Tan Y, Wang G, Lin X, Cai L (2009) Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Curr Med Chem 16(1):113–129PubMedCrossRef

go back to reference Du S, Shi H, Xiong L, Wang P, Shi Y (2022) Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol (Lausanne) 13:1011669PubMedCrossRef Du S, Shi H, Xiong L, Wang P, Shi Y (2022) Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol (Lausanne) 13:1011669PubMedCrossRef

go back to reference Kose T, Vera-Aviles M, Sharp PA, Latunde-Dada GO (2019) Curcumin and (-)- epigallocatechin-3-gallate protect murine MIN6 pancreatic beta-cells against iron toxicity and erastin-induced ferroptosis. Pharmaceuticals (Basel) 12(1) Kose T, Vera-Aviles M, Sharp PA, Latunde-Dada GO (2019) Curcumin and (-)- epigallocatechin-3-gallate protect murine MIN6 pancreatic beta-cells against iron toxicity and erastin-induced ferroptosis. Pharmaceuticals (Basel) 12(1)

go back to reference Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H (2018) The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep 8(1):968ADSPubMedPubMedCentralCrossRef Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, Izumikawa T, Conrad M, Bannai S, Sato H (2018) The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells. Sci Rep 8(1):968ADSPubMedPubMedCentralCrossRef

go back to reference Dolma S, Lessnick SL, Hahn WC, Stockwell BR (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3(3):285–296PubMedCrossRef Dolma S, Lessnick SL, Hahn WC, Stockwell BR (2003) Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3(3):285–296PubMedCrossRef

go back to reference Wei Z, Shaohuan Q, Pinfang K, Chao S (2022) Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway. Cardiovasc Ther 2022:3159717PubMedPubMedCentralCrossRef Wei Z, Shaohuan Q, Pinfang K, Chao S (2022) Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway. Cardiovasc Ther 2022:3159717PubMedPubMedCentralCrossRef

go back to reference Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10(1):9–17PubMedCrossRef Dixon SJ, Stockwell BR (2014) The role of iron and reactive oxygen species in cell death. Nat Chem Biol 10(1):9–17PubMedCrossRef

go back to reference Wang N, Ma H, Li J, Meng C, Zou J, Wang H, Liu K, Liu M, Xiao X, Zhang H, Wang K (2021) HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol 150:65–76PubMedCrossRef Wang N, Ma H, Li J, Meng C, Zou J, Wang H, Liu K, Liu M, Xiao X, Zhang H, Wang K (2021) HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes. J Mol Cell Cardiol 150:65–76PubMedCrossRef

go back to reference Zhang W, Lu J, Wang Y, Sun P, Gao T, Xu N, Zhang Y, Xie W (2023) Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and ferroptosis through activating AMPK pathway. Int J Mol Sci 24(1) Zhang W, Lu J, Wang Y, Sun P, Gao T, Xu N, Zhang Y, Xie W (2023) Canagliflozin attenuates lipotoxicity in cardiomyocytes by inhibiting inflammation and ferroptosis through activating AMPK pathway. Int J Mol Sci 24(1)

go back to reference Chen H, Wang C, Liu Z, He X, Tang W, He L, Feng Y, Liu D, Yin Y, Li T (2022) Ferroptosis and its multifaceted role in cancer: mechanisms and therapeutic approach. Antioxidants (Basel) 11(8) Chen H, Wang C, Liu Z, He X, Tang W, He L, Feng Y, Liu D, Yin Y, Li T (2022) Ferroptosis and its multifaceted role in cancer: mechanisms and therapeutic approach. Antioxidants (Basel) 11(8)

go back to reference Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S (2000) Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal 2(4):665–671PubMedCrossRef Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S (2000) Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal 2(4):665–671PubMedCrossRef

go back to reference Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T, Mehr L, Aichler M, Walch A, Lamp D, Jastroch M, Miyamoto S, Wurst W, Ursini F, Arner ESJ, Fradejas-Villar N, Schweizer U, Zischka H, Friedmann Angeli JP, Conrad M (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172(3):409–422 e421PubMedCrossRef Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T, Mehr L, Aichler M, Walch A, Lamp D, Jastroch M, Miyamoto S, Wurst W, Ursini F, Arner ESJ, Fradejas-Villar N, Schweizer U, Zischka H, Friedmann Angeli JP, Conrad M (2018) Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172(3):409–422 e421PubMedCrossRef

go back to reference Baseler WA, Dabkowski ER, Jagannathan R, Thapa D, Nichols CE, Shepherd DL, Croston TL, Powell M, Razunguzwa TT, Lewis SE, Schnell DM, Hollander JM (2013) Reversal of mitochondrial proteomic loss in type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. Am J Physiol Regul Integr Comp Physiol 304(7):R553-565PubMedPubMedCentralCrossRef Baseler WA, Dabkowski ER, Jagannathan R, Thapa D, Nichols CE, Shepherd DL, Croston TL, Powell M, Razunguzwa TT, Lewis SE, Schnell DM, Hollander JM (2013) Reversal of mitochondrial proteomic loss in type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase. Am J Physiol Regul Integr Comp Physiol 304(7):R553-565PubMedPubMedCentralCrossRef

go back to reference Lutchmansingh FK, Hsu JW, Bennett FI, Badaloo AV, McFarlane-Anderson N, Gordon-Strachan GM, Wright-Pascoe RA, Jahoor F, Boyne MS (2018) Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS ONE 13(6):e0198626PubMedPubMedCentralCrossRef Lutchmansingh FK, Hsu JW, Bennett FI, Badaloo AV, McFarlane-Anderson N, Gordon-Strachan GM, Wright-Pascoe RA, Jahoor F, Boyne MS (2018) Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS ONE 13(6):e0198626PubMedPubMedCentralCrossRef

go back to reference Bruni A, Pepper AR, Pawlick RL, Gala-Lopez B, Gamble AF, Kin T, Seeberger K, Korbutt GS, Bornstein SR, Linkermann A, Shapiro AMJ (2018) Ferroptosis-inducing agents compromise in vitro human islet viability and function. Cell Death Dis 9(6):595PubMedPubMedCentralCrossRef Bruni A, Pepper AR, Pawlick RL, Gala-Lopez B, Gamble AF, Kin T, Seeberger K, Korbutt GS, Bornstein SR, Linkermann A, Shapiro AMJ (2018) Ferroptosis-inducing agents compromise in vitro human islet viability and function. Cell Death Dis 9(6):595PubMedPubMedCentralCrossRef

go back to reference Liu M, Kong XY, Yao Y, Wang XA, Yang W, Wu H, Li S, Ding JW, Yang J (2022) The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review. Ann Transl Med 10(6):368PubMedPubMedCentralCrossRef Liu M, Kong XY, Yao Y, Wang XA, Yang W, Wu H, Li S, Ding JW, Yang J (2022) The critical role and molecular mechanisms of ferroptosis in antioxidant systems: a narrative review. Ann Transl Med 10(6):368PubMedPubMedCentralCrossRef

go back to reference Chen C, Chen W, Zhou X, Li Y, Pan X, Chen X (2022) Hyperbaric oxygen protects HT22 cells and PC12 cells from damage caused by oxygen-glucose deprivation/reperfusion via the inhibition of Nrf2/System Xc-/GPX4 axis-mediated ferroptosis. PLoS ONE 17(11):e0276083PubMedPubMedCentralCrossRef Chen C, Chen W, Zhou X, Li Y, Pan X, Chen X (2022) Hyperbaric oxygen protects HT22 cells and PC12 cells from damage caused by oxygen-glucose deprivation/reperfusion via the inhibition of Nrf2/System Xc-/GPX4 axis-mediated ferroptosis. PLoS ONE 17(11):e0276083PubMedPubMedCentralCrossRef

go back to reference Sun R, Liu M, Xu K, Pu Y, Huang J, Liu J, Zhang J, Yin L, Pu Y (2022) Ferroptosis is involved in the benzene-induced hematotoxicity in mice via iron metabolism, oxidative stress and NRF2 signaling pathway. Chem Biol Interact 362:110004PubMedCrossRef Sun R, Liu M, Xu K, Pu Y, Huang J, Liu J, Zhang J, Yin L, Pu Y (2022) Ferroptosis is involved in the benzene-induced hematotoxicity in mice via iron metabolism, oxidative stress and NRF2 signaling pathway. Chem Biol Interact 362:110004PubMedCrossRef

go back to reference Wang Y, Chen J, Li S, Zhang X, Guo Z, Hu J, Shao X, Song N, Zhao Y, Li H, Yang G, Xu C, Wei C (2020) Exogenous spermine attenuates rat diabetic cardiomyopathy via suppressing ROS-p53 mediated downregulation of calcium-sensitive receptor. Redox Biol 32:101514PubMedPubMedCentralCrossRef Wang Y, Chen J, Li S, Zhang X, Guo Z, Hu J, Shao X, Song N, Zhao Y, Li H, Yang G, Xu C, Wei C (2020) Exogenous spermine attenuates rat diabetic cardiomyopathy via suppressing ROS-p53 mediated downregulation of calcium-sensitive receptor. Redox Biol 32:101514PubMedPubMedCentralCrossRef

go back to reference Ge ZD, Lian Q, Mao X, Xia Z (2019) Current status and challenges of NRF2 as a potential therapeutic target for diabetic cardiomyopathy. Int Heart J 60(3):512–520PubMedCrossRef Ge ZD, Lian Q, Mao X, Xia Z (2019) Current status and challenges of NRF2 as a potential therapeutic target for diabetic cardiomyopathy. Int Heart J 60(3):512–520PubMedCrossRef

go back to reference Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB (2018) Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol 9:114PubMedPubMedCentralCrossRef Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB (2018) Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol 9:114PubMedPubMedCentralCrossRef

go back to reference Li G, Yang L, Feng L, Yang J, Li Y, An J, Li D, Xu Y, Gao Y, Li J, Liu J, Yang L, Qi Z (2020) Syringaresinol protects against type 1 diabetic cardiomyopathy by alleviating inflammation responses, cardiac fibrosis, and oxidative stress. Mol Nutr Food Res 64(18):e2000231PubMedCrossRef Li G, Yang L, Feng L, Yang J, Li Y, An J, Li D, Xu Y, Gao Y, Li J, Liu J, Yang L, Qi Z (2020) Syringaresinol protects against type 1 diabetic cardiomyopathy by alleviating inflammation responses, cardiac fibrosis, and oxidative stress. Mol Nutr Food Res 64(18):e2000231PubMedCrossRef

go back to reference Li X, Chen J, Yuan S, Zhuang X, Qiao T (2022) Activation of the P62-Keap1-NRF2 pathway protects against ferroptosis in radiation-induced lung injury. Oxid Med Cell Longev 2022:8973509PubMedPubMedCentral Li X, Chen J, Yuan S, Zhuang X, Qiao T (2022) Activation of the P62-Keap1-NRF2 pathway protects against ferroptosis in radiation-induced lung injury. Oxid Med Cell Longev 2022:8973509PubMedPubMedCentral

go back to reference Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD (2020) Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol 27(4):436–447PubMedPubMedCentralCrossRef Anandhan A, Dodson M, Schmidlin CJ, Liu P, Zhang DD (2020) Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis. Cell Chem Biol 27(4):436–447PubMedPubMedCentralCrossRef

go back to reference Carpi-Santos R, Calaza KC (2018) Alterations in system x(c)(-) expression in the retina of type 1 diabetic rats and the role of Nrf2. Mol Neurobiol 55(10):7941–7948PubMedCrossRef Carpi-Santos R, Calaza KC (2018) Alterations in system x(c)(-) expression in the retina of type 1 diabetic rats and the role of Nrf2. Mol Neurobiol 55(10):7941–7948PubMedCrossRef

go back to reference Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K (2011) Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys 508(1):101–109PubMedCrossRef Harada N, Kanayama M, Maruyama A, Yoshida A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M, Itoh K (2011) Nrf2 regulates ferroportin 1-mediated iron efflux and counteracts lipopolysaccharide-induced ferroportin 1 mRNA suppression in macrophages. Arch Biochem Biophys 508(1):101–109PubMedCrossRef

go back to reference Agyeman AS, Chaerkady R, Shaw PG, Davidson NE, Visvanathan K, Pandey A, Kensler TW (2012) Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res Treat 132(1):175–187PubMedCrossRef Agyeman AS, Chaerkady R, Shaw PG, Davidson NE, Visvanathan K, Pandey A, Kensler TW (2012) Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res Treat 132(1):175–187PubMedCrossRef

go back to reference Gu J, Cheng Y, Wu H, Kong L, Wang S, Xu Z, Zhang Z, Tan Y, Keller BB, Zhou H, Wang Y, Xu Z, Cai L (2017) Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy. Diabetes 66(2):529–542PubMedCrossRef Gu J, Cheng Y, Wu H, Kong L, Wang S, Xu Z, Zhang Z, Tan Y, Keller BB, Zhou H, Wang Y, Xu Z, Cai L (2017) Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy. Diabetes 66(2):529–542PubMedCrossRef

go back to reference Tian H, Xiong Y, Zhang Y, Leng Y, Tao J, Li L, Qiu Z, Xia Z (2021) Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress Chaperones 27(2):149–164PubMedCrossRef Tian H, Xiong Y, Zhang Y, Leng Y, Tao J, Li L, Qiu Z, Xia Z (2021) Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress Chaperones 27(2):149–164PubMedCrossRef

go back to reference Wang X, Chen X, Zhou W, Men H, Bao T, Sun Y, Wang Q, Tan Y, Keller BB, Tong Q, Zheng Y, Cai L (2022) Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B 12(2):708–722PubMedCrossRef Wang X, Chen X, Zhou W, Men H, Bao T, Sun Y, Wang Q, Tan Y, Keller BB, Tong Q, Zheng Y, Cai L (2022) Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B 12(2):708–722PubMedCrossRef

go back to reference Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z, Ding Z, Tan X (2022) 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway. Oxid Med Cell Longev 2022:3027514PubMedPubMedCentralCrossRef Wu S, Zhu J, Wu G, Hu Z, Ying P, Bao Z, Ding Z, Tan X (2022) 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway. Oxid Med Cell Longev 2022:3027514PubMedPubMedCentralCrossRef

go back to reference Zhang W, Xu X, Kao R, Mele T, Kvietys P, Martin CM, Rui T (2014) Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS ONE 9(9):e107639ADSPubMedPubMedCentralCrossRef Zhang W, Xu X, Kao R, Mele T, Kvietys P, Martin CM, Rui T (2014) Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS ONE 9(9):e107639ADSPubMedPubMedCentralCrossRef

go back to reference Wen C, Liu C, Li Y, Xia T, Zhang X, Xue S, Olatunji OJ (2022) Ameliorative potentials of the ethanolic extract from Lycium chinense leaf extract against diabetic cardiomyopathy. Insight into oxido-inflammatory and apoptosis modulation. Biomed Pharmacother 154:113583PubMedCrossRef Wen C, Liu C, Li Y, Xia T, Zhang X, Xue S, Olatunji OJ (2022) Ameliorative potentials of the ethanolic extract from Lycium chinense leaf extract against diabetic cardiomyopathy. Insight into oxido-inflammatory and apoptosis modulation. Biomed Pharmacother 154:113583PubMedCrossRef

go back to reference Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327(5963):296–300ADSPubMedCrossRef Schroder K, Zhou R, Tschopp J (2010) The NLRP3 inflammasome: a sensor for metabolic danger? Science 327(5963):296–300ADSPubMedCrossRef

go back to reference Fix C, Bingham K, Carver W (2011) Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine 53(1):19–28PubMedCrossRef Fix C, Bingham K, Carver W (2011) Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine 53(1):19–28PubMedCrossRef

go back to reference Bracey NA, Gershkovich B, Chun J, Vilaysane A, Meijndert HC, Wright JR Jr, Fedak PW, Beck PL, Muruve DA, Duff HJ (2014) Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J Biol Chem 289(28):19571–19584PubMedPubMedCentralCrossRef Bracey NA, Gershkovich B, Chun J, Vilaysane A, Meijndert HC, Wright JR Jr, Fedak PW, Beck PL, Muruve DA, Duff HJ (2014) Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J Biol Chem 289(28):19571–19584PubMedPubMedCentralCrossRef

go back to reference Zhang X, Fu Y, Li H, Shen L, Chang Q, Pan L, Hong S, Yin X (2018) H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose. J Cell Mol Med 22(3):1816–1825PubMedPubMedCentralCrossRef Zhang X, Fu Y, Li H, Shen L, Chang Q, Pan L, Hong S, Yin X (2018) H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose. J Cell Mol Med 22(3):1816–1825PubMedPubMedCentralCrossRef

go back to reference Gao R, Shi H, Chang S, Gao Y, Li X, Lv C, Yang H, Xiang H, Yang J, Xu L, Tang Y (2019) The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction. Int Immunopharmacol 74:105575PubMedCrossRef Gao R, Shi H, Chang S, Gao Y, Li X, Lv C, Yang H, Xiang H, Yang J, Xu L, Tang Y (2019) The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction. Int Immunopharmacol 74:105575PubMedCrossRef

go back to reference Dror E, Dalmas E, Meier DT, Wueest S, Thevenet J, Thienel C, Timper K, Nordmann TM, Traub S, Schulze F, Item F, Vallois D, Pattou F, Kerr-Conte J, Lavallard V, Berney T, Thorens B, Konrad D, Boni-Schnetzler M, Donath MY (2017) Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18(3):283–292PubMedCrossRef Dror E, Dalmas E, Meier DT, Wueest S, Thevenet J, Thienel C, Timper K, Nordmann TM, Traub S, Schulze F, Item F, Vallois D, Pattou F, Kerr-Conte J, Lavallard V, Berney T, Thorens B, Konrad D, Boni-Schnetzler M, Donath MY (2017) Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat Immunol 18(3):283–292PubMedCrossRef

go back to reference Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horvath B, Mukhopadhyay B, Becker L, Hasko G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P (2010) Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 56(25):2115–2125PubMedPubMedCentralCrossRef Rajesh M, Mukhopadhyay P, Batkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horvath B, Mukhopadhyay B, Becker L, Hasko G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P (2010) Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 56(25):2115–2125PubMedPubMedCentralCrossRef

go back to reference Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, Zhang M, Zhang Y, An F (2014) NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE 9(8):e104771ADSPubMedPubMedCentralCrossRef Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, Zhang M, Zhang Y, An F (2014) NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE 9(8):e104771ADSPubMedPubMedCentralCrossRef

go back to reference Cheng K, Huang Y, Wang C (2021) 1,25(OH)(2)D(3) Inhibited ferroptosis in zebrafish liver cells (ZFL) by regulating Keap1-Nrf2-GPx4 and NF-kappaB-hepcidin axis. Int J Mol Sci 22(21) Cheng K, Huang Y, Wang C (2021) 1,25(OH)(2)D(3) Inhibited ferroptosis in zebrafish liver cells (ZFL) by regulating Keap1-Nrf2-GPx4 and NF-kappaB-hepcidin axis. Int J Mol Sci 22(21)

go back to reference Zou C, Liu X, Xie R, Bao Y, Jin Q, Jia X, Li L, Liu R (2017) Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. Biochem Biophys Res Commun 486(4):930–936PubMedCrossRef Zou C, Liu X, Xie R, Bao Y, Jin Q, Jia X, Li L, Liu R (2017) Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. Biochem Biophys Res Commun 486(4):930–936PubMedCrossRef

go back to reference Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463–477PubMedCrossRef Levine B, Klionsky DJ (2004) Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 6(4):463–477PubMedCrossRef

go back to reference Mellor KM, Reichelt ME, Delbridge LM (2011) Autophagy anomalies in the diabetic myocardium. Autophagy 7(10):1263–1267PubMedCrossRef Mellor KM, Reichelt ME, Delbridge LM (2011) Autophagy anomalies in the diabetic myocardium. Autophagy 7(10):1263–1267PubMedCrossRef

go back to reference Dewanjee S, Vallamkondu J, Kalra RS, John A, Reddy PH, Kandimalla R (2021) Autophagy in the diabetic heart: a potential pharmacotherapeutic target in diabetic cardiomyopathy. Ageing Res Rev 68:101338PubMedCrossRef Dewanjee S, Vallamkondu J, Kalra RS, John A, Reddy PH, Kandimalla R (2021) Autophagy in the diabetic heart: a potential pharmacotherapeutic target in diabetic cardiomyopathy. Ageing Res Rev 68:101338PubMedCrossRef

go back to reference Park E, Chung SW (2019) ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis 10(11):822PubMedPubMedCentralCrossRef Park E, Chung SW (2019) ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis 10(11):822PubMedPubMedCentralCrossRef

go back to reference Yin H, Xu L, Porter NA (2011) Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 111(10):5944–5972PubMedCrossRef Yin H, Xu L, Porter NA (2011) Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 111(10):5944–5972PubMedCrossRef

go back to reference Latunde-Dada GO (2017) Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj 1861(8):1893–1900PubMedCrossRef Latunde-Dada GO (2017) Ferroptosis: role of lipid peroxidation, iron and ferritinophagy. Biochim Biophys Acta Gen Subj 1861(8):1893–1900PubMedCrossRef

go back to reference Sheng SY, Li JM, Hu XY, Wang Y (2023) Regulated cell death pathways in cardiomyopathy. Acta Pharmacol Sin Sheng SY, Li JM, Hu XY, Wang Y (2023) Regulated cell death pathways in cardiomyopathy. Acta Pharmacol Sin

go back to reference Zhao C, Yu D, He Z, Bao L, Feng L, Chen L, Liu Z, Hu X, Zhang N, Wang T, Fu Y (2021) Endoplasmic reticulum stress-mediated autophagy activation is involved in cadmium-induced ferroptosis of renal tubular epithelial cells. Free Radic Biol Med 175:236–248PubMedCrossRef Zhao C, Yu D, He Z, Bao L, Feng L, Chen L, Liu Z, Hu X, Zhang N, Wang T, Fu Y (2021) Endoplasmic reticulum stress-mediated autophagy activation is involved in cadmium-induced ferroptosis of renal tubular epithelial cells. Free Radic Biol Med 175:236–248PubMedCrossRef

go back to reference Chen HY, Xiao ZZ, Ling X, Xu RN, Zhu P, Zheng SY (2021) ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy. Mol Med 27(1):14PubMedPubMedCentralCrossRef Chen HY, Xiao ZZ, Ling X, Xu RN, Zhu P, Zheng SY (2021) ELAVL1 is transcriptionally activated by FOXC1 and promotes ferroptosis in myocardial ischemia/reperfusion injury by regulating autophagy. Mol Med 27(1):14PubMedPubMedCentralCrossRef

go back to reference Sha W, Hu F, Xi Y, Chu Y, Bu S (2021) Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res 2021:9999612PubMedPubMedCentralCrossRef Sha W, Hu F, Xi Y, Chu Y, Bu S (2021) Mechanism of ferroptosis and its role in type 2 diabetes mellitus. J Diabetes Res 2021:9999612PubMedPubMedCentralCrossRef

go back to reference Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G (2020) Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol 11:42PubMedPubMedCentralCrossRef Chen Y, Hua Y, Li X, Arslan IM, Zhang W, Meng G (2020) Distinct types of cell death and the implication in diabetic cardiomyopathy. Front Pharmacol 11:42PubMedPubMedCentralCrossRef

go back to reference He J, Li Z, Xia P, Shi A, FuChen X, Zhang J, Yu P (2022) Ferroptosis and ferritinophagy in diabetes complications. Mol Metab 60:101470PubMedPubMedCentralCrossRef He J, Li Z, Xia P, Shi A, FuChen X, Zhang J, Yu P (2022) Ferroptosis and ferritinophagy in diabetes complications. Mol Metab 60:101470PubMedPubMedCentralCrossRef

go back to reference Ghildiyal M, Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10(2):94–108PubMedPubMedCentralCrossRef Ghildiyal M, Zamore PD (2009) Small silencing RNAs: an expanding universe. Nat Rev Genet 10(2):94–108PubMedPubMedCentralCrossRef

go back to reference Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297PubMedCrossRef Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297PubMedCrossRef

go back to reference Roma-Rodrigues C, Raposo LR, Fernandes AR (2015) MicroRNAs based therapy of hypertrophic cardiomyopathy: the road traveled so far. Biomed Res Int 2015:983290PubMedPubMedCentralCrossRef Roma-Rodrigues C, Raposo LR, Fernandes AR (2015) MicroRNAs based therapy of hypertrophic cardiomyopathy: the road traveled so far. Biomed Res Int 2015:983290PubMedPubMedCentralCrossRef

go back to reference Liu B, Wang B, Zhang X, Lock R, Nash T, Vunjak-Novakovic G (2021) Cell type-specific microRNA therapies for myocardial infarction. Sci Transl Med 13(580) Liu B, Wang B, Zhang X, Lock R, Nash T, Vunjak-Novakovic G (2021) Cell type-specific microRNA therapies for myocardial infarction. Sci Transl Med 13(580)

go back to reference Olson EN (2014) MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med 6(239):239ps233CrossRef Olson EN (2014) MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci Transl Med 6(239):239ps233CrossRef

go back to reference Wong LL, Wang J, Liew OW, Richards AM, Chen YT (2016) MicroRNA and heart failure. Int J Mol Sci 17(4):502PubMedPubMedCentralCrossRef Wong LL, Wang J, Liew OW, Richards AM, Chen YT (2016) MicroRNA and heart failure. Int J Mol Sci 17(4):502PubMedPubMedCentralCrossRef

go back to reference Schellinger IN, Wagenhauser M, Chodisetti G, Mattern K, Dannert A, Petzold A, Jakubizka-Smorag J, Emrich F, Haunschild J, Schuster A, Schwob E, Schulz K, Maegdefessel L, Spin JM, Stumvoll M, Hasenfuss G, Tsao PS, Raaz U (2021) MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening. Mol Ther Nucleic Acids 24:188–199PubMedPubMedCentralCrossRef Schellinger IN, Wagenhauser M, Chodisetti G, Mattern K, Dannert A, Petzold A, Jakubizka-Smorag J, Emrich F, Haunschild J, Schuster A, Schwob E, Schulz K, Maegdefessel L, Spin JM, Stumvoll M, Hasenfuss G, Tsao PS, Raaz U (2021) MicroRNA miR-29b regulates diabetic aortic remodeling and stiffening. Mol Ther Nucleic Acids 24:188–199PubMedPubMedCentralCrossRef

go back to reference Kim JH (2020) The potential role of MicroRNA in diabetic cardiomyopathy. Diabetes Metab J 44(1):54–55PubMedPubMedCentralCrossRef Kim JH (2020) The potential role of MicroRNA in diabetic cardiomyopathy. Diabetes Metab J 44(1):54–55PubMedPubMedCentralCrossRef

go back to reference Du H, Yin Z, Zhao Y, Li H, Dai B, Fan J, He M, Nie X, Wang CY, Wang DW, Chen C (2021) miR-320a induces pancreatic beta cells dysfunction in diabetes by inhibiting MafF. Mol Ther Nucleic Acids 26:444–457PubMedPubMedCentralCrossRef Du H, Yin Z, Zhao Y, Li H, Dai B, Fan J, He M, Nie X, Wang CY, Wang DW, Chen C (2021) miR-320a induces pancreatic beta cells dysfunction in diabetes by inhibiting MafF. Mol Ther Nucleic Acids 26:444–457PubMedPubMedCentralCrossRef

go back to reference Xiao W, Zheng D, Chen X, Yu B, Deng K, Ma J, Wen X, Hu Y, Hou J (2021) Long non-coding RNA MIAT is involved in the regulation of pyroptosis in diabetic cardiomyopathy via targeting miR-214–3p. iScience 24(12):103518ADSPubMedPubMedCentralCrossRef Xiao W, Zheng D, Chen X, Yu B, Deng K, Ma J, Wen X, Hu Y, Hou J (2021) Long non-coding RNA MIAT is involved in the regulation of pyroptosis in diabetic cardiomyopathy via targeting miR-214–3p. iScience 24(12):103518ADSPubMedPubMedCentralCrossRef

go back to reference Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, Li X, Bai Y, Cheng Y (2021) MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ 766:142191ADSPubMedCrossRef Wang C, Liu G, Yang H, Guo S, Wang H, Dong Z, Li X, Bai Y, Cheng Y (2021) MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ 766:142191ADSPubMedCrossRef

go back to reference Guo R, Nair S (2017) Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention. Biochim Biophys Acta Mol Basis Dis 1863(8):2070–2077PubMedCrossRef Guo R, Nair S (2017) Role of microRNA in diabetic cardiomyopathy: from mechanism to intervention. Biochim Biophys Acta Mol Basis Dis 1863(8):2070–2077PubMedCrossRef

go back to reference Fuhrmann DC, Brune B (2022) A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis. Redox Biol 54:102365PubMedPubMedCentralCrossRef Fuhrmann DC, Brune B (2022) A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis. Redox Biol 54:102365PubMedPubMedCentralCrossRef

go back to reference Zhao F, Li B, Wei YZ, Zhou B, Wang H, Chen M, Gan XD, Wang ZH, Xiong SX (2013) MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes. J Huazhong Univ Sci Technolog Med Sci 33(6):834–839PubMedCrossRef Zhao F, Li B, Wei YZ, Zhou B, Wang H, Chen M, Gan XD, Wang ZH, Xiong SX (2013) MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes. J Huazhong Univ Sci Technolog Med Sci 33(6):834–839PubMedCrossRef

go back to reference Qi R, Bai Y, Wei Y, Liu N, Shi B (2022) The role of non-coding RNAs in ferroptosis regulation. J Trace Elem Med Biol 70:126911PubMedCrossRef Qi R, Bai Y, Wei Y, Liu N, Shi B (2022) The role of non-coding RNAs in ferroptosis regulation. J Trace Elem Med Biol 70:126911PubMedCrossRef

go back to reference Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I (2019) The role of Nrf2 activity in cancer development and progression. Cancers (Basel) 11(11) Zimta AA, Cenariu D, Irimie A, Magdo L, Nabavi SM, Atanasov AG, Berindan-Neagoe I (2019) The role of Nrf2 activity in cancer development and progression. Cancers (Basel) 11(11)

go back to reference Zheng D, Ma J, Yu Y, Li M, Ni R, Wang G, Chen R, Li J, Fan GC, Lacefield JC, Peng T (2015) Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia 58(8):1949–1958PubMedPubMedCentralCrossRef Zheng D, Ma J, Yu Y, Li M, Ni R, Wang G, Chen R, Li J, Fan GC, Lacefield JC, Peng T (2015) Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice. Diabetologia 58(8):1949–1958PubMedPubMedCentralCrossRef

go back to reference Purohit PK, Edwards R, Tokatlidis K, Saini N (2019) miR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells. RNA Biol 16(7):918–929PubMedPubMedCentralCrossRef Purohit PK, Edwards R, Tokatlidis K, Saini N (2019) miR-195 regulates mitochondrial function by targeting mitofusin-2 in breast cancer cells. RNA Biol 16(7):918–929PubMedPubMedCentralCrossRef

go back to reference Costantino S, Paneni F, Luscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37(6):572–576PubMedCrossRef Costantino S, Paneni F, Luscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37(6):572–576PubMedCrossRef

go back to reference Ding C, Ding X, Zheng J, Wang B, Li Y, Xiang H, Dou M, Qiao Y, Tian P, Xue W (2020) miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury. Cell Death Dis 11(10):929PubMedPubMedCentralCrossRef Ding C, Ding X, Zheng J, Wang B, Li Y, Xiang H, Dou M, Qiao Y, Tian P, Xue W (2020) miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury. Cell Death Dis 11(10):929PubMedPubMedCentralCrossRef

go back to reference Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114(6):597–605PubMedCrossRef Goldin A, Beckman JA, Schmidt AM, Creager MA (2006) Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114(6):597–605PubMedCrossRef

go back to reference Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, Chen X, Zhang Y, Wang M, Qian J, Huang W, Lum H, Wu G, Liang G (2020) MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun 11(1):2148ADSPubMedPubMedCentralCrossRef Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, Chen X, Zhang Y, Wang M, Qian J, Huang W, Lum H, Wu G, Liang G (2020) MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun 11(1):2148ADSPubMedPubMedCentralCrossRef

go back to reference Bodiga VL, Eda SR, Bodiga S (2014) Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev 19(1):49–63PubMedCrossRef Bodiga VL, Eda SR, Bodiga S (2014) Advanced glycation end products: role in pathology of diabetic cardiomyopathy. Heart Fail Rev 19(1):49–63PubMedCrossRef

go back to reference Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J (2009) Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13(8B):1751–1764PubMedCrossRef Ma H, Li SY, Xu P, Babcock SA, Dolence EK, Brownlee M, Li J, Ren J (2009) Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med 13(8B):1751–1764PubMedCrossRef

go back to reference Chen J, Sun Z, Jin M, Tu Y, Wang S, Yang X, Chen Q, Zhang X, Han Y, Pi R (2017) Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-kappaB pathway. J Neuroimmunol 305:108–114PubMedCrossRef Chen J, Sun Z, Jin M, Tu Y, Wang S, Yang X, Chen Q, Zhang X, Han Y, Pi R (2017) Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-kappaB pathway. J Neuroimmunol 305:108–114PubMedCrossRef

go back to reference Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, An P, Huang S, Pan J, Chen HZ, Chen J, Linkermann A, Min J, Wang F (2020) Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ Res 127(4):486–501PubMedCrossRef Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P, Gao F, Yu Y, Song Z, Wu Q, An P, Huang S, Pan J, Chen HZ, Chen J, Linkermann A, Min J, Wang F (2020) Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis. Circ Res 127(4):486–501PubMedCrossRef

go back to reference Mirlohi MS, Yaghooti H, Shirali S, Aminasnafi A, Olapour S (2018) Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major. Ann Hematol 97(4):679–684PubMedCrossRef Mirlohi MS, Yaghooti H, Shirali S, Aminasnafi A, Olapour S (2018) Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with beta-thalassemia major. Ann Hematol 97(4):679–684PubMedCrossRef